Evidence map›Paper›PMID 41699279›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2026

Meningioma theranostics: a retrospective analysis of somatostatin receptor PET/CT imaging and peptide receptor radionuclide therapy.

L Degryse, L Teles, S De Vleeschouwer, L Boeckxstaens, S Jentjens, W Deckers, M Lambrecht, J F Daisne, K Van Laere, A J A T Braat and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

L DegryseNuclear Medicine, University Hospitals Leuven, Herestraat 49, 3000, Louvain, Belgium.ORCID 0000-0002-6984-0687
L TelesSolid Tumors Department, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.ORCID 0009-0008-8941-4619
S De VleeschouwerNeurosurgery, University Hospitals Leuven, Louvain, Belgium.ORCID 0000-0002-9576-9917
L BoeckxstaensNuclear Medicine, University Hospitals Leuven, Herestraat 49, 3000, Louvain, Belgium.ORCID 0000-0001-5906-1113
S JentjensNuclear Medicine, University Hospitals Leuven, Herestraat 49, 3000, Louvain, Belgium.ORCID 0000-0003-3602-9078
W DeckersNuclear Medicine, University Hospitals Leuven, Herestraat 49, 3000, Louvain, Belgium.ORCID 0000-0002-0907-7384
M LambrechtRadiation Oncology, University Hospitals Leuven, Louvain, Belgium.ORCID 0000-0002-8746-2691
J F DaisneRadiation Oncology, Iridium Cancer Network, Wilrijk, Belgium.ORCID 0000-0001-8584-4189
K Van LaereNuclear Medicine, University Hospitals Leuven, Herestraat 49, 3000, Louvain, Belgium.ORCID 0000-0001-5200-7245
A J A T BraatNuclear Medicine, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.ORCID 0000-0002-8824-8697
P M ClementGeneral Medical Oncology, University Hospitals Leuven, Louvain, Belgium.
K GoffinNuclear Medicine, University Hospitals Leuven, Herestraat 49, 3000, Louvain, Belgium.ORCID 0000-0002-7453-0229
C M DerooseNuclear Medicine, University Hospitals Leuven, Herestraat 49, 3000, Louvain, Belgium. christophe.deroose@uzleuven.be.ORCID 0000-0002-6080-1577

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study aims to evaluate differences in PET/CT imaging of meningioma using both gallium-68- and fluorine-18-labelled somatostatin receptor (SSTR) tracers, to characterize incidentally detected meningiomas on SSTR PET/CT, and to analyse institutional experience with Peptide Receptor Radionuclide Therapy (PRRT) in meningioma.

methodsThis single centre retrospective study included all SSTR PET/CT scans of meningioma patients (2007-2024) performed with [

resultsOf 4,136 SSTR PET/CTs, 152 patients with 171 SSTR-expressing meningiomas were included. Incidental meningiomas were found in 3.7% of patients imaged for unrelated indications. Quantitative analysis of 86 lesions (≥ 1 cm

conclusionSSTR PET/CT enables high-contrast meningioma visualisation. [

Indexed as

Meningeal NeoplasmsMeningiomaPositron Emission Tomography Computed TomographyPrecision MedicineReceptors, PeptideReceptors, SomatostatinAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedOctreotideRetrospective StudiesOctreotideReceptors, PeptideReceptors, Somatostatin177Lu-DOTATATE[18F]AlF-NOTA-octreotideMeningiomaPRRTSomatostatin receptor PET-CTSSTR PET-CT

Identifiers

PMID41699279

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.